Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

Coronavirus disease-2019 (COVID-19) associated pneumonia may progress into acute respiratory distress syndrome (ARDS). Some patients develop features of macrophage activation syndrome (MAS). Elevated levels of IL-6 were reported to be associated with severe disease, and anti-IL-6R tocilizumab has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Mert, Ali, Vahaboğlu, Haluk, Arslan, Ferhat, Batirel, Ayşe, Saraçoğlu, Kemal Tolga, Bastug, Aliye, Çağatay, Atahan, Irmak, İlim, Dizman, Gülçin Telli, Ertenli, İhsan, Altunal, Lütfiye Nilsun, Sengel, Buket Ertürk, Bayram, Mehmet, Omma, Ahmet, Amikishiyev, Shirkhan, Aypak, Adalet, Bes, Cemal, Bolukçu, Sibel, Içten, Sacit, Topeli, Arzu, Bektaş, Murat, Arslan, Birsen Yiğit, Öztürk, Sinan, Çomoğlu, Şenol, Aydin, Selda, Küçükşahin, Orhan, Içaçan, Ozan Cemal, Ince, Burak, Aghamuradov, Sarvan, Mutlu, Melek Yalçin, Şimşek, Funda, Emre, Salih, Ustun, Cemal, Ergen, Pinar, Aydin, Özlem, Koç, Meliha Meriç, Sevindik, Ömür Gökmen, Odabaşı, Zekaver, Korten, Volkan, Bodur, Hurrem, Güner, Rahmet, Ünal, Serhat, Kocak, Mehmet, Gül, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436189/
https://www.ncbi.nlm.nih.gov/pubmed/34515808
http://dx.doi.org/10.1007/s00296-021-04965-6

Ejemplares similares

Ejemplares similares